Signal-averaged P wave duration predicts early recurrence of atrial fibrillation after cardioversion

Merritt H. Raitt, Kenneth D. Ingram, S. Michael Thurman

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Thirty-two patients had signal-averaged P wave duration measured after electrical cardioversion of AF, and were followed for 1 year or until there was a recurrence. The use of antiarrhythmic medications was left to the discretion of the attending physician. Among 20 patients not taking antiarrhythmic medication, the 11 patients who had a recurrence of AF within 3 months of cardioversion had a significantly longer signal-averaged P wave duration compared to the 9 patients who did not (148 ± 17 vs 135 ± 20 ms, P = 0.005). There was no difference in clinical parameters or left atrial diameter. A signal-averaged P wave duration cutoff anywhere between 130 and 135 ms correctly classified 85% of patients with a sensitivity of 81% and a specificity of 89%. In patients taking antiarrhythmic medications, signal- averaged P wave duration did not correlate with the risk of recurrence. In patients not taking antiarrhythmic medications, signal-averaged P wave duration can be used to predict the risk of an early recurrence of AF after cardioversion. The poor predictive value in patients taking antiarrhythmics may be due to changes in the atrial refractory period, which are not reflected in P wave duration.

Original languageEnglish (US)
Pages (from-to)259-265
Number of pages7
JournalPACE - Pacing and Clinical Electrophysiology
Volume23
Issue number2
StatePublished - 2000

Fingerprint

Electric Countershock
Atrial Fibrillation
Recurrence
Physicians

Keywords

  • AF cardioversion
  • P wave signal averaging

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Signal-averaged P wave duration predicts early recurrence of atrial fibrillation after cardioversion. / Raitt, Merritt H.; Ingram, Kenneth D.; Thurman, S. Michael.

In: PACE - Pacing and Clinical Electrophysiology, Vol. 23, No. 2, 2000, p. 259-265.

Research output: Contribution to journalArticle

Raitt, Merritt H. ; Ingram, Kenneth D. ; Thurman, S. Michael. / Signal-averaged P wave duration predicts early recurrence of atrial fibrillation after cardioversion. In: PACE - Pacing and Clinical Electrophysiology. 2000 ; Vol. 23, No. 2. pp. 259-265.
@article{da1c802c961b407cb5eed904f96b1637,
title = "Signal-averaged P wave duration predicts early recurrence of atrial fibrillation after cardioversion",
abstract = "Thirty-two patients had signal-averaged P wave duration measured after electrical cardioversion of AF, and were followed for 1 year or until there was a recurrence. The use of antiarrhythmic medications was left to the discretion of the attending physician. Among 20 patients not taking antiarrhythmic medication, the 11 patients who had a recurrence of AF within 3 months of cardioversion had a significantly longer signal-averaged P wave duration compared to the 9 patients who did not (148 ± 17 vs 135 ± 20 ms, P = 0.005). There was no difference in clinical parameters or left atrial diameter. A signal-averaged P wave duration cutoff anywhere between 130 and 135 ms correctly classified 85{\%} of patients with a sensitivity of 81{\%} and a specificity of 89{\%}. In patients taking antiarrhythmic medications, signal- averaged P wave duration did not correlate with the risk of recurrence. In patients not taking antiarrhythmic medications, signal-averaged P wave duration can be used to predict the risk of an early recurrence of AF after cardioversion. The poor predictive value in patients taking antiarrhythmics may be due to changes in the atrial refractory period, which are not reflected in P wave duration.",
keywords = "AF cardioversion, P wave signal averaging",
author = "Raitt, {Merritt H.} and Ingram, {Kenneth D.} and Thurman, {S. Michael}",
year = "2000",
language = "English (US)",
volume = "23",
pages = "259--265",
journal = "PACE - Pacing and Clinical Electrophysiology",
issn = "0147-8389",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Signal-averaged P wave duration predicts early recurrence of atrial fibrillation after cardioversion

AU - Raitt, Merritt H.

AU - Ingram, Kenneth D.

AU - Thurman, S. Michael

PY - 2000

Y1 - 2000

N2 - Thirty-two patients had signal-averaged P wave duration measured after electrical cardioversion of AF, and were followed for 1 year or until there was a recurrence. The use of antiarrhythmic medications was left to the discretion of the attending physician. Among 20 patients not taking antiarrhythmic medication, the 11 patients who had a recurrence of AF within 3 months of cardioversion had a significantly longer signal-averaged P wave duration compared to the 9 patients who did not (148 ± 17 vs 135 ± 20 ms, P = 0.005). There was no difference in clinical parameters or left atrial diameter. A signal-averaged P wave duration cutoff anywhere between 130 and 135 ms correctly classified 85% of patients with a sensitivity of 81% and a specificity of 89%. In patients taking antiarrhythmic medications, signal- averaged P wave duration did not correlate with the risk of recurrence. In patients not taking antiarrhythmic medications, signal-averaged P wave duration can be used to predict the risk of an early recurrence of AF after cardioversion. The poor predictive value in patients taking antiarrhythmics may be due to changes in the atrial refractory period, which are not reflected in P wave duration.

AB - Thirty-two patients had signal-averaged P wave duration measured after electrical cardioversion of AF, and were followed for 1 year or until there was a recurrence. The use of antiarrhythmic medications was left to the discretion of the attending physician. Among 20 patients not taking antiarrhythmic medication, the 11 patients who had a recurrence of AF within 3 months of cardioversion had a significantly longer signal-averaged P wave duration compared to the 9 patients who did not (148 ± 17 vs 135 ± 20 ms, P = 0.005). There was no difference in clinical parameters or left atrial diameter. A signal-averaged P wave duration cutoff anywhere between 130 and 135 ms correctly classified 85% of patients with a sensitivity of 81% and a specificity of 89%. In patients taking antiarrhythmic medications, signal- averaged P wave duration did not correlate with the risk of recurrence. In patients not taking antiarrhythmic medications, signal-averaged P wave duration can be used to predict the risk of an early recurrence of AF after cardioversion. The poor predictive value in patients taking antiarrhythmics may be due to changes in the atrial refractory period, which are not reflected in P wave duration.

KW - AF cardioversion

KW - P wave signal averaging

UR - http://www.scopus.com/inward/record.url?scp=0033982185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033982185&partnerID=8YFLogxK

M3 - Article

C2 - 10709235

AN - SCOPUS:0033982185

VL - 23

SP - 259

EP - 265

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - 2

ER -